首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1743895

全球豬隻疫苗市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Swine Vaccines Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年06月01日 | 出版商:

Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球豬隻疫苗市場規模預計將從 2024 年的 21.6 億美元成長到 2033 年的 34.9 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 5.49%。

受豬群傳染病日益普及的推動，豬隻疫苗市場可望強勁成長。隨著全球豬肉需求持續成長，制定有效的疫苗接種策略以確保豬群健康和生產力變得至關重要。新型病原體的出現以及先前已控制的疾病的復發，使得疫苗製劑的持續研發成為必要。各公司正在大力投資創新技術，例如重組疫苗和基於mRNA的解決方案，這些技術有望提高疫苗的有效性和安全性，從而應對養豬生產者面臨的日益嚴峻的挑戰。

此外，畜牧養殖戶對生物安全措施的意識不斷增強，這對豬隻疫苗市場產生了重大影響。生產者越來越認知到疫苗接種作為全面豬群管理策略關鍵組成部分的重要性。這種觀念的轉變正在促進積極主動的疾病預防，從而提高疫苗接種率，並最終增強豬群的抵抗。用於監測和管理疫苗接種計劃的數位工具整合也越來越受到關注，使養殖戶能夠最佳化豬群健康管理實踐並提高整體生產力。

此外，全球養豬業的擴張，尤其是在新興市場的擴張，為豬隻疫苗市場帶來了豐厚的利潤。隨著各國努力提高畜牧業生產能力以滿足日益成長的消費需求，採用先進的疫苗接種計畫變得至關重要。疫苗製造商與農業組織之間的合作有望促進知識轉移，並改善這些地區獲得疫苗接種技術的途徑。豬疫苗市場的未來前景光明，其特點是持續創新、疾病管理意識的提高以及對改善動物健康和福利的承諾。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了競爭態勢以及領先公司採用的關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新以及潛在投資領域。本部分將深入探討未來市場發展與成長前景。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：豬疫苗公司的競爭格局

豬疫苗市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Biogenesis Bago

公司概況
公司收入
產品
最新動態

Bioveta

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Ceva SantA(C) Animale

公司概況
公司收入
產品
最新動態

Elanco Animal Health Incorporated

公司概況
公司收入
產品
最新動態

HIPRA

公司概況
公司收入
產品
最新動態

Indian Immunologicals Limited

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Phibro Animal Health Corporation

公司概況
公司收入
產品
最新動態

Vaxxinova

公司概況
公司收入
產品
最新動態

Virbac

公司概況
公司收入
產品
最新動態

Zoetis Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11214069

Global Swine Vaccines Market size is anticipated to grow from USD 2.16 Billion in 2024 to USD 3.49 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.49% during the forecast period of 2026 to 2033.

The swine vaccines market is set for robust growth, driven by the increasing prevalence of infectious diseases affecting pig populations. As the global demand for pork continues to rise, the need for effective vaccination strategies to ensure herd health and productivity becomes paramount. The emergence of novel pathogens and the resurgence of previously controlled diseases necessitate ongoing research and development in vaccine formulations. Companies are investing heavily in innovative technologies, such as recombinant vaccines and mRNA-based solutions, which promise enhanced efficacy and safety profiles, thereby addressing the evolving challenges faced by swine producers.

Moreover, the growing awareness of biosecurity measures among livestock farmers is significantly influencing the swine vaccines market. Producers are increasingly recognizing the importance of vaccination as a critical component of comprehensive herd management strategies. This shift in mindset is fostering a proactive approach to disease prevention, leading to higher vaccination rates and, consequently, a more resilient swine population. The integration of digital tools for monitoring and managing vaccination schedules is also gaining traction, enabling farmers to optimize their herd health management practices and improve overall productivity.

Additionally, the expansion of the global swine industry, particularly in emerging markets, presents lucrative opportunities for the swine vaccines market. As countries strive to enhance their livestock production capabilities to meet growing consumer demand, the adoption of advanced vaccination programs becomes essential. Collaborations between vaccine manufacturers and agricultural organizations are expected to facilitate knowledge transfer and improve access to vaccination technologies in these regions. The future of the swine vaccines market appears promising, characterized by continuous innovation, increased awareness of disease management, and a commitment to enhancing animal health and welfare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

Inactivated vaccines
Live attenuated vaccines
Recombinant vaccines
Subunit vaccines
Toxoid vaccines
Other products

By Disease Type

Porcine reproductive and respiratory syndrome (PRRS)
Porcine circovirus type 2 (PCV2)
Mycoplasma hyopneumoniae
Classical swine fever (CSF)
Swine influenza
Erysipelas
Foot-and-Mouth disease (FMD)
African swine fever (ASF)
Porcine parvovirus
Other disease types

By End-user

Veterinary hospitals & clinics
Swine farms
Research institutes
COMPANIES PROFILED
Biogenesis Bago
Bioveta
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Elanco Animal Health Incorporated
HIPRA
Indian Immunologicals Limited
Merck & Co. Inc.
Phibro Animal Health Corporation
Vaxxinova
Virbac
Zoetis Inc.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. SWINE VACCINES INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Disease Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL SWINE VACCINES MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Inactivated vaccines Historic and Forecast Sales By Regions
5.4. Live attenuated vaccines Historic and Forecast Sales By Regions
5.5. Recombinant vaccines Historic and Forecast Sales By Regions
5.6. Subunit vaccines Historic and Forecast Sales By Regions
5.7. Toxoid vaccines Historic and Forecast Sales By Regions
5.8. Other products Historic and Forecast Sales By Regions

6. GLOBAL SWINE VACCINES MARKET ANALYSIS BY DISEASE TYPE

6.1. Overview By Disease Type
6.2. Historical and Forecast Data Analysis By Disease Type
6.3. Porcine reproductive and respiratory syndrome (PRRS) Historic and Forecast Sales By Regions
6.4. Porcine circovirus type 2 (PCV2) Historic and Forecast Sales By Regions
6.5. Mycoplasma hyopneumoniae Historic and Forecast Sales By Regions
6.6. Classical swine fever (CSF) Historic and Forecast Sales By Regions
6.7. Swine influenza Historic and Forecast Sales By Regions
6.8. Erysipelas Historic and Forecast Sales By Regions
6.9. Foot-and-Mouth disease (FMD) Historic and Forecast Sales By Regions
6.10. African swine fever (ASF) Historic and Forecast Sales By Regions
6.11. Porcine parvovirus Historic and Forecast Sales By Regions
6.12. Other disease types Historic and Forecast Sales By Regions

7. GLOBAL SWINE VACCINES MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Veterinary hospitals & clinics Historic and Forecast Sales By Regions
7.4. Swine farms Historic and Forecast Sales By Regions
7.5. Research institutes Historic and Forecast Sales By Regions

8. GLOBAL SWINE VACCINES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SWINE VACCINES COMPANIES

9.1. Swine Vaccines Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF SWINE VACCINES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Biogenesis Bago
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Bioveta
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Boehringer Ingelheim International GmbH
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Ceva SantA(C) Animale
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Elanco Animal Health Incorporated
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. HIPRA
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Indian Immunologicals Limited
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Merck & Co. Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Phibro Animal Health Corporation
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Vaxxinova
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Virbac
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Zoetis Inc
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Inactivated vaccines Market Sales By Geography (USD MN)
Live attenuated vaccines Market Sales By Geography (USD MN)
Recombinant vaccines Market Sales By Geography (USD MN)
Subunit vaccines Market Sales By Geography (USD MN)
Toxoid vaccines Market Sales By Geography (USD MN)
Other products Market Sales By Geography (USD MN)
Analysis By Disease Type (USD MN)
Porcine reproductive and respiratory syndrome (PRRS) Market Sales By Geography (USD MN)
Porcine circovirus type 2 (PCV2) Market Sales By Geography (USD MN)
Mycoplasma hyopneumoniae Market Sales By Geography (USD MN)
Classical swine fever (CSF) Market Sales By Geography (USD MN)
Swine influenza Market Sales By Geography (USD MN)
Erysipelas Market Sales By Geography (USD MN)
Foot-and-Mouth disease (FMD) Market Sales By Geography (USD MN)
African swine fever (ASF) Market Sales By Geography (USD MN)
Porcine parvovirus Market Sales By Geography (USD MN)
Other disease types Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Veterinary hospitals & clinics Market Sales By Geography (USD MN)
Swine farms Market Sales By Geography (USD MN)
Research institutes Market Sales By Geography (USD MN)
Global Swine Vaccines Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Swine Vaccines Report
Market Research Process
Market Research Methodology
Global Swine Vaccines Market Size, By Regions (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Disease Type
Market Attractiveness Analysis By End-user
Market Attractiveness Analysis By Regions
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Inactivated vaccines Market Sales By Geography (USD MN)
Live attenuated vaccines Market Sales By Geography (USD MN)
Recombinant vaccines Market Sales By Geography (USD MN)
Subunit vaccines Market Sales By Geography (USD MN)
Toxoid vaccines Market Sales By Geography (USD MN)
Other products Market Sales By Geography (USD MN)
Global Market Analysis By Disease Type (USD MN)
Porcine reproductive and respiratory syndrome (PRRS) Market Sales By Geography (USD MN)
Porcine circovirus type 2 (PCV2) Market Sales By Geography (USD MN)
Mycoplasma hyopneumoniae Market Sales By Geography (USD MN)
Classical swine fever (CSF) Market Sales By Geography (USD MN)
Swine influenza Market Sales By Geography (USD MN)
Erysipelas Market Sales By Geography (USD MN)
Foot-and-Mouth disease (FMD) Market Sales By Geography (USD MN)
African swine fever (ASF) Market Sales By Geography (USD MN)
Porcine parvovirus Market Sales By Geography (USD MN)
Other disease types Market Sales By Geography (USD MN)
Global Market Analysis By End-user (USD MN)
Veterinary hospitals & clinics Market Sales By Geography (USD MN)
Swine farms Market Sales By Geography (USD MN)
Research institutes Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis